MedTrace Logo

Patient Navigator Intervention for Diabetic Retinopathy

NCT05188703 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2026-03-11

Study results available
· View outcomes & findings →

Summary

This is a pilot study of a patient navigator intervention for people living with diabetes and at high risk of diabetic blindness. The investigators are assessing the feasibility and acceptability of the intervention in preparation for a clinical trial.

Conditions

Interventions

BEHAVIORAL

Patient Navigation

Participants will be assigned to a patient navigator and will have quarterly appointments. Patient navigators will assist with access and coordination of medical care.

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Kristen Nwanyanwu, MD, MHS · Yale University

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-25
Primary Completion
2024-09-19
Completion
2024-09-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05188703 on ClinicalTrials.gov